$10.700
+2.007 (+18.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AKTX Prediction & Forecast by Similar Chart Analysis
Alphio's AKTX stock price prediction model matches the current Akari Therapeutics PLC tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.72 (+0.23%). The 1-week path is $11.10 (+3.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Akari Therapeutics PLC Stock?
Akari Therapeutics appears to be a good buy right now due to its recent price increase of 36.31% over the last five days and a strong analyst price target of $30, which suggests significant upside potential from the current price of $10.70. The main risk is the company's negative net income, which was -14,455,000 USD in Q1 2026, indicating ongoing financial challenges.
AKTX stock price ended at $10.70 on Friday, after rising +18.76%
Akari Therapeutics PLC (AKTX) last closed at $10.7, gaining +18.76%. These facts feed the 1-day and 1-week AKTX price prediction above.
Analyst Consensus
Akari Therapeutics PLC (AKTX): 2 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Akari Therapeutics PLC (AKTX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches AKTX, ranked by similarity.
Seasonality analysis for AKTX
Historically the probability of a positive August return for AKTX is 34.92%. June offers the highest probability of a positive month at 50.00%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AKTX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.21 | $1.36 | $1.42 | -87.25% |
| Sep 2026 | $1.18 | $1.26 | $1.28 | -88.26% |
| Oct 2026 | $0.84 | $1.05 | $1.14 | -90.16% |
| Nov 2026 | $0.90 | $1.01 | $1.23 | -90.57% |
| Dec 2026 | $1.21 | $1.24 | $1.46 | -88.45% |
In 2026, Akari Therapeutics PLC (AKTX) is projected to range from $0.84 to $1.46.
Akari Therapeutics PLC 2026 monthly forecast
In Aug 2026, Akari Therapeutics PLC is projected to average $1.36, with a low of $1.21 and high of $1.42.
In Sep 2026, Akari Therapeutics PLC is projected to average $1.26, with a low of $1.18 and high of $1.28.
In Oct 2026, Akari Therapeutics PLC is projected to average $1.05, with a low of $0.84 and high of $1.14.
In Nov 2026, Akari Therapeutics PLC is projected to average $1.01, with a low of $0.90 and high of $1.23.
In Dec 2026, Akari Therapeutics PLC is projected to average $1.24, with a low of $1.21 and high of $1.46.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.